OTCMKTS:CYDY

Cytodyn Stock Predictions

Healthcare > Biotechnology

Buy CYDY

*Your capital is at risk

$0.247

-0.0012 (-0.484%)

At Close: Jun 26, 2026

Currently predicting for Mon, 29 Jun 2026

CYDY Live board

Community Bull/Bear

Target Next close

Join the CYDY prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

CYDY Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For CYDY

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

CYDY Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT CYTODYN INC

CytoDyn Inc. operates as a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of human immunodeficiency virus (HIV), cancer, immunology, and novel coronavirus disease (COVID-19)....

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
JLL $299.78	5.10%	Jun 24
X XMAX $8.34	5.40%	Jun 24
TWI $7.56	6.08%	Jun 22
IAC $42.63	5.08%	Jun 12
DHI $146.71	13.35%	Jun 10

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by